These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 1315592

  • 21. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence.
    Pompili M, Mirante VG, Rondinara G, Fassati LR, Piscaglia F, Agnes S, Covino M, Ravaioli M, Fagiuoli S, Gasbarrini G, Rapaccini GL.
    Liver Transpl; 2005 Sep; 11(9):1117-26. PubMed ID: 16123960
    [Abstract] [Full Text] [Related]

  • 22. Combined ethanol injection therapy and radiofrequency ablation therapy in percutaneous treatment of hepatocellular carcinoma larger than 4 cm.
    Vallone P, Catalano O, Izzo F, Siani A.
    Cardiovasc Intervent Radiol; 2006 Sep; 29(4):544-51. PubMed ID: 16528626
    [Abstract] [Full Text] [Related]

  • 23. [Treatment of primary hepatocarcinoma with chemoembolization and alcohol injection. Personal experience].
    Florio F, Nardella M, Balzano S, Andriulli A, Caturelli E, Siena D, Bisceglia M, Fusilli S, Scarale MG, Cammisa M.
    Radiol Med; 1994 Dec; 88(6):821-6. PubMed ID: 7878242
    [Abstract] [Full Text] [Related]

  • 24. [Non-vascular interventional radiology--percutaneous ethanol injection (PEI) in hepatocellular carcinoma smaller than 3 cm in diameter].
    Ebara M, Kita K, Yoshikawa M, Ohto M.
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3311-8. PubMed ID: 2551256
    [Abstract] [Full Text] [Related]

  • 25. A comparison of chemoembolization with conventional chemotherapy and symptomatic treatment in cirrhotic patients with hepatocellular carcinoma.
    Bayraktar Y, Balkanci F, Kayhan B, Uzunalimoglu B, Gokoz A, Ozisik Y, Gurakar A, Van Thiel DH, Firat D.
    Hepatogastroenterology; 1996 Sep; 43(9):681-7. PubMed ID: 8799415
    [Abstract] [Full Text] [Related]

  • 26. Adjuvant hepatic chemotherapy after resection of solitary hepatocellular carcinoma associated with hepatitis B virus cirrhosis.
    Wen J, Shen WL, Yang SH.
    Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):224-7. PubMed ID: 16698580
    [Abstract] [Full Text] [Related]

  • 27. [Combined percutaneous ethanol injection through liver puncture and transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma].
    Li C, Shi Z, Hao Y.
    Zhonghua Zhong Liu Za Zhi; 2001 Nov; 23(6):490-2. PubMed ID: 11859718
    [Abstract] [Full Text] [Related]

  • 28. Radiofrequency ablation of hepatocellular carcinoma in cirrhotic patients.
    Guglielmi A, Ruzzenente A, Battocchia A, Tonon A, Fracastoro G, Cordiano C.
    Hepatogastroenterology; 2003 Nov; 50(50):480-4. PubMed ID: 12749252
    [Abstract] [Full Text] [Related]

  • 29. Percutaneous ethanol injection therapy for recurrent hepatocellular carcinoma.
    Tanikawa K, Majima Y.
    Hepatogastroenterology; 1993 Aug; 40(4):324-7. PubMed ID: 8406300
    [Abstract] [Full Text] [Related]

  • 30. Hepatocellular carcinoma and octreotide: treatment results in prospectively assigned patients with advanced tumor and cirrhosis stage.
    Plentz RR, Tillmann HL, Kubicka S, Bleck JS, Gebel M, Manns MP, Rudolph KL.
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1422-8. PubMed ID: 16105131
    [Abstract] [Full Text] [Related]

  • 31. Prognosis of hepatocellular carcinoma associated with Child class B and C cirrhosis in relation to treatment: a multivariate analysis of 411 patients at a single center.
    Ueno S, Tanabe G, Nuruki K, Oketani M, Komorizono Y, Hokotate H, Fukukura Y, Baba Y, Imamura Y, Aikou T.
    J Hepatobiliary Pancreat Surg; 2002 Sep; 9(4):469-77. PubMed ID: 12483269
    [Abstract] [Full Text] [Related]

  • 32. [Prognostic factors influencing postoperative survival in patients with </= 3 cm small hepatocellular carcinoma].
    Wu FS, Zhao WH, Liang TB, Ren GP, Ma ZM, Teng LS.
    Zhonghua Wai Ke Za Zhi; 2005 May 01; 43(9):579-83. PubMed ID: 15938929
    [Abstract] [Full Text] [Related]

  • 33. Risk factors of survival after percutaneous radiofrequency ablation of hepatocellular carcinoma.
    Peng ZW, Zhang YJ, Chen MS, Liang HH, Li JQ, Zhang YQ, Lau WY.
    Surg Oncol; 2008 Jul 01; 17(1):23-31. PubMed ID: 17869095
    [Abstract] [Full Text] [Related]

  • 34. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection.
    Livraghi T, Giorgio A, Marin G, Salmi A, de Sio I, Bolondi L, Pompili M, Brunello F, Lazzaroni S, Torzilli G.
    Radiology; 1995 Oct 01; 197(1):101-8. PubMed ID: 7568806
    [Abstract] [Full Text] [Related]

  • 35. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
    De Cobelli F, Castrucci M, Sironi S, Livraghi T, Venturini M, Salvioni M, Del Maschio A.
    Radiol Med; 1994 Dec 01; 88(6):806-17. PubMed ID: 7878241
    [Abstract] [Full Text] [Related]

  • 36. Survival of patients with early hepatocellular carcinoma treated by percutaneous alcohol injection.
    Andriulli A, De Sio I, Brunello F, Salmi A, Solmi L, Facciorusso D, Caturelli E, Perri F.
    Aliment Pharmacol Ther; 2006 May 01; 23(9):1329-35. PubMed ID: 16629938
    [Abstract] [Full Text] [Related]

  • 37. Hepatic resection for hepatocellular carcinoma in diameter of > or = 10 cm.
    Hanazaki K, Kajikawa S, Shimozawa N, Shimada K, Hiraguri M, Koide N, Adachi W, Amano J.
    Hepatogastroenterology; 2002 May 01; 49(44):518-23. PubMed ID: 11995486
    [Abstract] [Full Text] [Related]

  • 38. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients.
    Livraghi T, Bolondi L, Lazzaroni S, Marin G, Morabito A, Rapaccini GL, Salmi A, Torzilli G.
    Cancer; 1992 Feb 15; 69(4):925-9. PubMed ID: 1310435
    [Abstract] [Full Text] [Related]

  • 39. Surgical removal of a distinct subcutaneous metastasis of multilocular hepatocellular carcinoma 2 months after initial percutaneous ethanol injection therapy.
    Braune C, Widjaja A, Bartels M, Bleck JS, Flemming P, Manns MP, Klempnauer J, Gebel M.
    Z Gastroenterol; 2001 Sep 15; 39(9):789-92. PubMed ID: 11558070
    [Abstract] [Full Text] [Related]

  • 40. Ultrasound-guided percutaneous ethanol injection under general anesthesia for the treatment of hepatocellular carcinoma on cirrhosis: long-term results in 268 patients.
    Giorgio A, Tarantino L, de Stefano G, Perrotta A, Aloisio V, del Viscovo L, Alaia A, Lettieri G.
    Eur J Ultrasound; 2000 Dec 15; 12(2):145-54. PubMed ID: 11118922
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.